This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Thevax Genetics Vaccine Co., Ltd.. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Cheng-Yung Chang: Innovator in Hepatitis B Therapeutic Vaccines
Introduction
Cheng-Yung Chang is a prominent inventor based in Hsinchu County, Taiwan. He has made significant contributions to the field of medical research, particularly in the development of therapeutic vaccines for hepatitis B. His innovative work has the potential to impact public health positively.
Latest Patents
Cheng-Yung Chang holds a patent for a fusion protein designed for use as a hepatitis B therapeutic vaccine. This fusion protein comprises an antigen-presenting cell (APC)-binding domain or a CD91 receptor-binding domain, a protein transduction domain, and an antigen that includes a hepatitis B virus X protein deletion mutant. The protein transduction domain is a fusion polypeptide that consists of a T cell sensitizing signal-transducing peptide, a linker, and a translocation peptide. The APC-binding domain or the CD91 receptor-binding domain is located at the N-terminus of the fusion protein, while the antigen is situated at the C-terminus of the protein transduction domain. This innovative approach aims to enhance the efficacy of hepatitis B vaccines.
Career Highlights
Cheng-Yung Chang is associated with Thevax Genetics Vaccine Co., Ltd., where he continues to advance his research in vaccine development. His work is characterized by a commitment to improving therapeutic options for hepatitis B, showcasing his dedication to public health and innovation.
Collaborations
Cheng-Yung Chang collaborates with notable colleagues, including Chia-Mao Wu and Jiun-Ming Wu. These partnerships enhance the research and development efforts at Thevax Genetics Vaccine Co., Ltd., fostering a collaborative environment for innovation.
Conclusion
Cheng-Yung Chang is a key figure in the development of hepatitis B therapeutic vaccines, with a patent that reflects his innovative approach to medical research. His contributions are vital in the ongoing fight against hepatitis B, and his work continues to inspire advancements in vaccine technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile